Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
BMC Cancer
; 14: 23, 2014 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-24422949
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skull
/
Bone Neoplasms
/
Osteosarcoma
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Neoadjuvant Therapy
/
Facial Bones
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2014
Type:
Article